| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vifa2g03342 | ATGAGAGCTGACGAAGTTGAAGGAGTTTCCGCAGATAACCACAATCCTAACTCAGATATAGAACTCATTGGTGTTCATACTGAAAGATTACCTCACAATGTTTCACTCAACAAAAGAAGAGCTACCAAATTGAAAGTTTCAAATTCAACCTCTGCTATAGATCTTAACCATGGCAAATCACAACAAGTACAAGATGAAGAAAAAGAACAAGAAGAAGATTACGTTGAAGTCACTATGGATATTCAAGGCGAATCCATTGCTTTACACAGTGTTAAAACGGTTACAGGAAGTGGAATTAATGATGATGGTGAAGATGAGAAACGCGTATTGCTTGGGAAAGGAATGGAGAAGAAGAGGTCGTTTGGTGCTTCGTTTGTGCGAACTGCTTCGATTCGAATAAAGCATGTTTCTCAGGAATTGAAGAGACTGACTTCTTTTTCGAATTCGAATTCGAAACAAGTTGGACCTGAGAAGGTTTATGATAGGACTAAGTCTGCGGCTTCTCATGCTCTTATTGGACTTAAGTTTATTAATAAGAAGACTGATGGTGATGATGGTGTTGGATGGTTTGAGGTTGAGAAACAGTTTGAGATTCTCACGAATTCGAGGGAGGATGGTTTGCTTCATCGTTCTCTCTTTGCGAAATGCATAGGGATGAACAAAGAATCTGAGGCTTTTGCTGGTGAGCTATTTGATGCTATGTCTAGGAGGAGAAATATTCATGGAGATTCAATTAATAAGGCACAGTTGAAGGATTTTTGGGACCAGATTTCTGACCAGAGTTTTGATTCTAGGCTTAGAACATTCTTTGACATGGTTGATAAAGACGCTGACGGAAGAATCACTGAAGAAGAAATTAAACAGATTATTTGCCTTAGTGCCACTACAAACAAACTCTCAAACATACAGAAGCAGGCAGAAGAATATGCTGCTTTGATCATGGAAGAACTAGACCCTGATGGCACAGGATTTATCATGGTAAATGACCTAGAGATACTCTTGTTGCATGGACCAACTCATTCTACAAGAGGAGATAGTAAATACCTGAGCCAAATGCTAAGCATAAAGCTTAAGGCTACATATGAATACAATCCTGTTAGGAAGAGGTATAGAGATGCCATTTACTTTCTGCAGGACAATTGGCAAAGAACTTGGATACTGGTACTATGGATTGGTGTTATGTGTGGTCTATTTGCCTACAAATTCATGCAATACAGAAGGAAAGCTGCCTATGAGGTTATGGGTCATTGTGTGTGCATGGCTAAAGGTGCAGCTGAGACACTCAAATTGAACATGGCAATTATCTTGTTACCTGTTTGCCGTAACACTATCACATGGCTTAGGAACAAGACCAAACTCGGCATTGCTGTTCCTTTTGATGACAACCTCAACTTCCACAAGGTGATAGCTGTGGCTATAGCAATTGGAGTTGGTGTACATGCTGTTTATCATCTTACTTGTGATTTTCCTCGCCTTCTTCATGCAAATAGTGAAAAGTACAAGCAGATGGAACCATTTTTCGGAAACCAACCATCAAATTATTGGCATTTTGTGAAATCATGGGAAGGGGTCACAGGGATTTCAATGGTTGTTTTAATGACAATAGCCTTCACACTGGCTAGTCCTTGGTTAAGGAGAGGAAGGGTTAAGCTACCAAAACCCCTCAATAGTCTAACTGGTTTCAATGCTTTTTGGTATTCTCATCATCTCTTTGTATTTGTCTATGTCCTTTTGGTTGTGCATGGAATCAAACTTTACTTGACTAAGGAATGGTACAAGAAAACGACATGGATGTATTTGGCTATTCCCATCATCATTTATGCATTGGAAAGACTGACTCGAGCACTCAGATCAAGCATCAAGCCTGTGAGAATATTGAAGGTGGCTGTTTATCCTGGAAATGTGTTGGCTCTTCATATGTCAAAGCCTCAGGGGTTTAGATACAAGAGTGGACAATACATGTTTATAAACTGTGCTGCTGTCTCTCCATTTGAATGGCATCCATTTTCCATAACCTCTGCCCCAGGAGATGATTACCTTAGTGTTCACATCAGAACATTAGGTGACTGGACCAGGAGTCTCAGAGTCAAATTCTCAGAGAGTTGCCTTCCACCGACCCATGGGAAGAGTGGACTTCTAAGAGCTGAATGCATGCAAGGAGGGGATGCCAGTCCAAGTACTCTCCCTAAAGTATTGATCGATGGTCCTTATGGAGCGCCTGCACAAGACTACAAACAATATGAAGTGGTTTTACTTGTAGGCCTAGGAATTGGGGCTACCCCAATGATAAGTATATTGAAGGACATAGTGAATAATTTTAAGGCCATGGAAGAGGATGAAGGAAACACTATAGAAGAGGGAACAAGTGAGAACAGGGTTCATTTGATTGGTTTAAAGGGTGTCTATGAAGAAGGTGATGCTCGCTCTGCTCTTATTGCTATGCTTCAATCACTTAACCATGCTAAAAATGGCGTGGATATCGTCTCTGGAACACGCGTCAAGTCTCACTTTGCTAAACCTAATTGGCGCAGCGTCTACAAACGCATTGCGCTTAATCATCCACAAACGCGAGTCGGGGTGTTTTACTGTGGGCCACCGGCAATTACTAAAGAGCTTAGTCAATTAGCTTCAGATTTTTCTCACAACACAACAACCAAATATGATTTCCACAAGGAAAATTTTTAG | 2685 | 0.4071 | MRADEVEGVSADNHNPNSDIELIGVHTERLPHNVSLNKRRATKLKVSNSTSAIDLNHGKSQQVQDEEKEQEEDYVEVTMDIQGESIALHSVKTVTGSGINDDGEDEKRVLLGKGMEKKRSFGASFVRTASIRIKHVSQELKRLTSFSNSNSKQVGPEKVYDRTKSAASHALIGLKFINKKTDGDDGVGWFEVEKQFEILTNSREDGLLHRSLFAKCIGMNKESEAFAGELFDAMSRRRNIHGDSINKAQLKDFWDQISDQSFDSRLRTFFDMVDKDADGRITEEEIKQIICLSATTNKLSNIQKQAEEYAALIMEELDPDGTGFIMVNDLEILLLHGPTHSTRGDSKYLSQMLSIKLKATYEYNPVRKRYRDAIYFLQDNWQRTWILVLWIGVMCGLFAYKFMQYRRKAAYEVMGHCVCMAKGAAETLKLNMAIILLPVCRNTITWLRNKTKLGIAVPFDDNLNFHKVIAVAIAIGVGVHAVYHLTCDFPRLLHANSEKYKQMEPFFGNQPSNYWHFVKSWEGVTGISMVVLMTIAFTLASPWLRRGRVKLPKPLNSLTGFNAFWYSHHLFVFVYVLLVVHGIKLYLTKEWYKKTTWMYLAIPIIIYALERLTRALRSSIKPVRILKVAVYPGNVLALHMSKPQGFRYKSGQYMFINCAAVSPFEWHPFSITSAPGDDYLSVHIRTLGDWTRSLRVKFSESCLPPTHGKSGLLRAECMQGGDASPSTLPKVLIDGPYGAPAQDYKQYEVVLLVGLGIGATPMISILKDIVNNFKAMEEDEGNTIEEGTSENRVHLIGLKGVYEEGDARSALIAMLQSLNHAKNGVDIVSGTRVKSHFAKPNWRSVYKRIALNHPQTRVGVFYCGPPAITKELSQLASDFSHNTTTKYDFHKENF | 894 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vifa2g03342 | 894 | MobiDBLite | consensus disorder prediction | 1 | 20 | - | - | |
| Vifa2g03342 | 894 | CDD | EFh | 224 | 290 | IPR002048 | GO:0005509 | |
| Vifa2g03342 | 894 | Pfam | Ferric reductase NAD binding domain | 747 | 778 | IPR013121 | GO:0016491 | |
| Vifa2g03342 | 894 | Pfam | FAD-binding domain | 622 | 740 | IPR013112 | GO:0016491 | |
| Vifa2g03342 | 894 | SUPERFAMILY | EF-hand | 190 | 339 | IPR011992 | - | |
| Vifa2g03342 | 894 | Pfam | Ferric reductase like transmembrane component | 423 | 579 | IPR013130 | - | |
| Vifa2g03342 | 894 | SUPERFAMILY | Riboflavin synthase domain-like | 622 | 739 | IPR017938 | - | |
| Vifa2g03342 | 894 | ProSiteProfiles | EF-hand calcium-binding domain profile. | 305 | 340 | IPR002048 | GO:0005509 | |
| Vifa2g03342 | 894 | CDD | EFh | 265 | 325 | IPR002048 | GO:0005509 | |
| Vifa2g03342 | 894 | SFLD | NADPH oxidase subgroup (NOX) | 73 | 779 | - | - | |
| Vifa2g03342 | 894 | PANTHER | NADPH OXIDASE | 225 | 894 | - | - | |
| Vifa2g03342 | 894 | Pfam | Ferric reductase NAD binding domain | 800 | 876 | IPR013121 | GO:0016491 | |
| Vifa2g03342 | 894 | Gene3D | Translation factors | 608 | 699 | - | - | |
| Vifa2g03342 | 894 | PRINTS | Cytochrome B-245 heavy chain signature | 729 | 742 | IPR000778 | GO:0016020|GO:0016491 | |
| Vifa2g03342 | 894 | PRINTS | Cytochrome B-245 heavy chain signature | 561 | 581 | IPR000778 | GO:0016020|GO:0016491 | |
| Vifa2g03342 | 894 | PRINTS | Cytochrome B-245 heavy chain signature | 752 | 769 | IPR000778 | GO:0016020|GO:0016491 | |
| Vifa2g03342 | 894 | PRINTS | Cytochrome B-245 heavy chain signature | 469 | 487 | IPR000778 | GO:0016020|GO:0016491 | |
| Vifa2g03342 | 894 | ProSiteProfiles | EF-hand calcium-binding domain profile. | 261 | 296 | IPR002048 | GO:0005509 | |
| Vifa2g03342 | 894 | Gene3D | - | 778 | 894 | IPR039261 | - | |
| Vifa2g03342 | 894 | FunFam | Respiratory burst oxidase homolog A | 160 | 282 | - | - | |
| Vifa2g03342 | 894 | FunFam | Respiratory burst oxidase homolog A | 609 | 701 | - | - | |
| Vifa2g03342 | 894 | SUPERFAMILY | Ferredoxin reductase-like, C-terminal NADP-linked domain | 730 | 879 | IPR039261 | - | |
| Vifa2g03342 | 894 | Gene3D | - | 160 | 282 | - | - | |
| Vifa2g03342 | 894 | MobiDBLite | consensus disorder prediction | 47 | 70 | - | - | |
| Vifa2g03342 | 894 | ProSiteProfiles | Ferredoxin reductase-type FAD binding domain profile. | 618 | 743 | IPR017927 | GO:0016491 | |
| Vifa2g03342 | 894 | Pfam | Respiratory burst NADPH oxidase | 161 | 264 | IPR013623 | GO:0004601|GO:0050664 | |
| Vifa2g03342 | 894 | CDD | NOX_Duox_like_FAD_NADP | 625 | 894 | - | - | |
| Vifa2g03342 | 894 | ProSitePatterns | EF-hand calcium-binding domain. | 274 | 286 | IPR018247 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vifa2g03342 | Vifa-Chr2 | 959725415 | 959730866 | Transposed |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vifa2g03342 | 13 | 894 | Miscellaneous Gene Families | AT5G47910 | 59.740 | 0.0 | 1078 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vifa2g03342 | K13447 | - | gmx:100800248 | 1360.51 |
| Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
|---|---|---|---|---|---|---|---|---|---|
| Vifa2g03342 | 2 | 959725415 | 959730866 | Vifa2g03342 | 2 | 959725415 | 959730866 | ECH |